NCT06879288

Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia After Elective Laparoscopic Cholecystectomy

Efficacy of Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia in Patients Undergoing Elective Laparoscopic Cholecystectomy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (actual)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 21 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study aimed to assess the efficiency of dexmedetomidine against magnesium sulfate as adjuvants to intraperitoneal bupivacaine for postoperative analgesia in individuals having elective laparoscopic cholecystectomy.

Detailed description

Pain after laparoscopy is less intense than after laparotomy, but laparoscopy is not pain free and analgesia after this type of surgery is inadequately studied. Intraperitoneal (IP) instillation/nebulization of local anesthetics has been used as a method for reducing postoperative pain and opioid use following laparoscopy through acting on visceral nociceptors of the peritoneum. Bupivacaine is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, and epidural and caudal blocks. It is available mixed with a small amount of epinephrine to increase the duration of its action. It typically begins working within 15 minutes and lasts for 2 to 8 hours. Dexmedetomidine is a selective alpha-2 (α2) adrenergic agonist known to have analgesic and sedative characteristics that can augment the duration of action of local anesthetics. Magnesium is an N-methyl-D-aspartate receptor antagonist in addition to its effects on calcium influx. The anti-inflammatory and opioid-sparing effects make it a popular component of opioid free anaesthesia. It is extensively used for perioperative analgesia in a dose of 30- to 50-mg/kg intravascular bolus followed by a 10- to 15-mg/kg/h infusion.

Conditions

• Dexmedetomidine
• Magnesium Sulfate
• Adjuvants
• Intraperitoneal Bupivacaine
• Postoperative Analgesia
• Elective Laparoscopic Cholecystectomy

Interventions

Type	Name	Description
DRUG	Bupivacaine	Patients received intraperitoneal bupivacaine only at the end of the operations.
DRUG	Dexmedetomidine	Patients received intraperitoneal bupivacaine plus dexmedetomidine at the end of the operations.
DRUG	Magnesium sulfate	Patients received intraperitoneal bupivacaine plus magnesium sulfate at the end of the operations.

Timeline

• Start date: 2023-07-01
• Primary completion: 2025-02-01
• Completion: 2025-02-01
• First posted: 2025-03-17
• Last updated: 2025-03-17

Locations

1 site across 1 country: Egypt